|
Press Releases |
|
|
|
Wednesday, September 16, 2015 |
|
Omnicare Trust PIERS to Accrue Contingent Interest |
Omnicare, Inc. announced today that, for the quarterly interest period beginning September 15, 2015, its Trust Preferred Income Equity Redeemable Securities will, subject to the terms of the Trust PIERS, accrue contingent interest at a rate of approximately $0.15 per $50 stated liquidation amount of the Trust PIERS. more info >> |
|
Wednesday, August 19, 2015 |
|
Omnicare Announces Conversion Rate Adjustments for Convertible Notes |
Omnicare, Inc. announced today an adjustment to the conversion rate of its (i) 3.75% Convertible Senior Subordinated Notes due 2025, (ii) 3.50% Convertible Senior Subordinated Notes due 2044, (iii) 3.25% Convertible Senior Debentures due 2035 and (iv) 3.25% Convertible Senior Exchange Debentures due 2035. more info >> |
|
Friday, July 24, 2015 |
|
Omnicare Reports Second-Quarter 2015 Financial Results |
Omnicare, Inc. (NYSE: OCR) reported today financial results for its second quarter ended June 30, 2015. more info >> |
|
Saturday, June 20, 2015 |
|
Omnicare's Series A and Series B Trust PIERS to Accrue Contingent Interest |
Omnicare, Inc. (NYSE: OCR) (the "Company") announced today that, for the period from June 15, 2015 to September 14, 2015, its Series A and Series B Trust Preferred Income Equity Redeemable Securities will accrue contingent interest at a rate of 0.125% of the average trading price of the Trust PIERS for the five trading days ended June 11, 2015, in addition to the continued accrual of regular cash interest. more info >> |
|
Friday, May 22, 2015 |
|
Omnicare Declares Quarterly Cash Dividend |
Omnicare, Inc. (NYSE:OCR) (the "Company") today announced that its Board of Directors has approved a quarterly cash dividend of $0.22 per share on the Company's common stock, to be paid on June 30, 2015, to all stockholders of record on June 12, 2015. more info >> |
|
Thursday, April 2, 2015 |
|
Omnicare to Report First-Quarter 2015 Financial Results and Hold Conference Call on Wednesday, April 29, 2015 |
Omnicare, Inc. (NYSE:OCR) will release its financial results for the first quarter of fiscal 2015 before the market opens on Wednesday, April 29, 2015. more info >> |
|
Saturday, March 28, 2015 |
|
Omnicare Announces Conversion Rate Adjustment for Convertible Notes; Series A and Series B Trust PIERS to Accrue Contingent Interest |
Omnicare, Inc. (NYSE: OCR) (the "Company") announced today an adjustment to the conversion rate of its 3.75% Convertible Senior Subordinated Notes due 2025 (the "2025 Notes"). more info >> |
|
Friday, March 6, 2015 |
|
Omnicare's Specialty Care Group Advanced Care Scripts (ACS) to Provide Specialty Pharmacy Services for Novartis' Farydak(R) |
Advanced Care Scripts (ACS), a leading specialty pharmacy and clinical services platform of Omnicare Specialty Care Group (SCG), is proud to be part of the limited distribution network for the Novartis drug Farydak(R) (panobinostat). more info >> |
|
Tuesday, March 3, 2015 |
|
Omnicare Specialty Care Group's ACS to Provide Specialty Pharmacy Services for Bayer's Nexavar(R) (sorafenib) and Stivarga(R) (regorafenib) |
Advanced Care Scripts (ACS), a leading specialty pharmacy and clinical services platform of Omnicare's Specialty Care Group, has been chosen to dispense Bayer's Nexavar(R) (sorafenib) and Stivarga(R) (regorafenib) as part of their limited distribution networks. more info >> |
|
Thursday, February 26, 2015 |
|
Omnicare Reports Fourth-Quarter and Full-Year 2014 Financial Results; Company Provides Full-Year 2015 Guidance |
Omnicare, Inc. (NYSE:OCR) reported today financial results for its fourth quarter and full year ended December 31, 2014. more info >> |
|
|
|
|
|
|
|
|
Latest Press Releases |
|
AGILON HEALTH (NYSE: AGL) INVESTOR ALERT: Kaplan Fox & Kilsheimer LLP Notifies Agilon Health Investors of a Class Action Lawsuit and May 20, 2024 Lead Plaintiff Deadline
May 10, 2024 08:33 HKT/SGT
|
|
|
SSR MINING (SSRM) INVESTOR ALERT: Kaplan Fox & Kilsheimer LLP Notifies SSR Mining Investors of a Class Action Lawsuit and May 17, 2024 Lead Plaintiff Deadline
May 10, 2024 08:26 HKT/SGT
|
|
|
CHEMOURS (NYSE: CC) ALERT: Kaplan Fox & Kilsheimer LLP Reminds Investors of Class Action Lawsuit and May 20, 2024 Lead Plaintiff Deadline
May 10, 2024 08:20 HKT/SGT
|
|
|
DOXIMITY (NYSE: DOCS) ALERT: Kaplan Fox & Kilsheimer LLP Reminds Investors of Class Action Lawsuit and June 17, 2024 Lead Plaintiff Deadline
May 10, 2024 08:13 HKT/SGT
|
|
|
特步宣布战略性出售K-Swiss及帕拉丁 并优化财务结构
May 9, 2024 20:28 HKT/SGT
|
|
|
特步宣佈戰略性出售K-Swiss及帕拉丁 並優化財務結構
May 9, 2024 20:25 HKT/SGT
|
|
|
Xtep Announces Strategic Divestiture of K-Swiss and Palladium and Enhanced Financial Structure
May 9, 2024 20:18 HKT/SGT
|
|
|
Paltalk, Inc. Reports Slight Increase in Revenue and 33% Reduction in Net Loss for First Quarter 2024
May 9, 2024 20:39 JST
|
|
|
ソニー独自のマイクロサージャリー支援ロボットを開発
May 9, 2024 18:00: JST
|
|
|
Honda、インドでの電動化の加速に向けた研究開発拠点をベンガルールに開設
May 9, 2024 13:50: JST
|
|
|
LEXUS、「LM」に6座仕様車を追加設定
May 9, 2024 13:45: JST
|
|
|
富士通、がんのタイプ分けなどのゲノム医療分野の課題を世界最高精度で解く、説明可能なAI技術を開発
May 9, 2024 13:30: JST
|
|
|
Honda Opens New R&D Facility in Bengaluru to Accelerate Electrification in India
May 9, 2024 14:13 JST
|
|
|
Malaysian Retail Sector Sees a 173% Growth in Hiring: foundit Insights Tracker
May 9, 2024 12:00 HKT/SGT
|
|
|
Fujitsu introduces "explainable AI" for use in genomic medicine and cancer treatment planning
May 9, 2024 10:41 JST
|
|
|
|
More News >> |
|
|
|
|
|